Bradycardia

Bradycardia
ICD-10	R00.1
ICD-9	427.81, 659.7, 785.9, 779.81

WikiDoc Resources for Bradycardia
Articles
Most recent articles on Bradycardia Most cited articles on Bradycardia Review articles on Bradycardia Articles on Bradycardia in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Bradycardia Images of Bradycardia Photos of Bradycardia Podcasts & MP3s on Bradycardia Videos on Bradycardia
Evidence Based Medicine
Cochrane Collaboration on Bradycardia Bandolier on Bradycardia TRIP on Bradycardia
Clinical Trials
Ongoing Trials on Bradycardia at Clinical Trials.gov Trial results on Bradycardia Clinical Trials on Bradycardia at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Bradycardia NICE Guidance on Bradycardia NHS PRODIGY Guidance FDA on Bradycardia CDC on Bradycardia
Books
Books on Bradycardia
News
Bradycardia in the news Be alerted to news on Bradycardia News trends on Bradycardia
Commentary
Blogs on Bradycardia
Definitions
Definitions of Bradycardia
Patient Resources / Community
Patient resources on Bradycardia Discussion groups on Bradycardia Patient Handouts on Bradycardia Directions to Hospitals Treating Bradycardia Risk calculators and risk factors for Bradycardia
Healthcare Provider Resources
Symptoms of Bradycardia Causes & Risk Factors for Bradycardia Diagnostic studies for Bradycardia Treatment of Bradycardia
Continuing Medical Education (CME)
CME Programs on Bradycardia
International
Bradycardia en Espanol Bradycardia en Francais
Business
Bradycardia in the Marketplace Patents on Bradycardia
Experimental / Informatics
List of terms related to Bradycardia

Cardiology Network
Discuss Bradycardia further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Bradycardia, as applied to adult medicine, is defined as a resting heart rate of under 60 beats per minute, though it is seldom symptomatic until the rate drops below 50 beat/min. Trained athletes tend to have slow resting heart rates, and resting bradycardia in athletes should not be considered abnormal if the individual has no symptoms associated with it.

The term relative bradycardia is used to explain a heart rate that, while not technically below 60 beats per minute, is considered too slow for the individual's current medical condition.

This cardiac arrhythmia can be underlain by several causes, which are best divided into cardiac and non-cardiac causes. Non-cardiac causes are usually secondary, and can involve drug use or abuse; metabolic or endocrine issues, especially in the thyroid; an electrolyte imbalance; neurologic factors; autonomic reflexes; situational factors such as prolonged bed rest; and autoimmunity. Cardiac causes include acute or chronic ischemic heart disease, vascular heart disease, valvular heart disease, or degenerative primary electrical disease. Ultimately, the causes act by three mechanisms: depressed automaticity of the heart, conduction block, or escape pacemakers and rhythms.

Causes

There are generally two types of problems that result in bradycardias: disorders of the sinus node, and disorders of the atrioventricular node (AV node).

With sinus node dysfunction (sometimes called sick sinus syndrome), there may be disordered automaticity or impaired conduction of the impulse from the sinus node into the surrounding atrial tissue (an "exit block"). It is difficult and sometimes impossible to assign a mechanism to any particular bradycardia, but the underlying mechanism is not clinically relevant to treatment, which is the same in both cases of sick sinus syndrome: a permanent pacemaker.

Atrioventricular conduction disturbances (aka: AV block; 1^o AV block, 2^o type I AV block, 2^o type II AV block, 3^o AV block) may result from impaired conduction in the AV node, or anywhere below it, such as in the bundle of HIS.

Patients with bradycardia have likely acquired it, as opposed to having it congenitally. Bradycardia is more common in older patients.

• 

Complete Differential Diagnosis of the Causes of Bradycardia

(In alphabetical order)

• Aceclidine
• Acepromazine
• Acetylcholinesterase inhibitor
• Adenosine
• Amiodarone
• Amodiaquine
• Anorexia Nervosa
• Apnea of prematurity
• Atenolol
• Atrioventricular Block
• Autonomic neuropathy
• Barbiturates
• Beta-blockers
• Bupivacaine
• Calcium channel blocker
• Cardiac arrhythmia
• Cardiac Dysrhythmias
• Cardiomegaly
• Catecholaminergic polymorphic ventricular tachycardia
• Cerebral Hemorrhage
• Cerebral venous sinus thrombosis
• Chronic Chagas' disease
• Clomipramine
• Congenital Long QT Syndrome
• Cushing reaction
• Cushing reflex
• Cushing's triad
• Detomidine
• Digitalis
• Diltiazem
• Diphenhydramine
• Donepezil
• Doxepin
• Drowning
• Emery-Dreifuss muscular dystrophy
• Enema
• Faget sign
• Fetal distress
• Gamma-Hydroxybutyric acid
• Gastric lavage
• Glyceryl trinitrate
• Grayanotoxin
• Hantavirus pulmonary syndrome
• Hellebore
• Holt-Oram syndrome
• Hydrocodone
• Hydroxyethyl starch
• Hypercalcemia
• Hyperkalemia
• Hypokalemia
• Hypothermia
• Hypothyroidism
• Ibuprofen
• Intracranial pressure
• Isosorbide dinitrate
• Ivabradine
• Levobetaxolol
• Levobupivacaine
• Lidocaine
• Lithium
• Mammalian diving reflex
• Medetomidine
• Mefloquine
• Mepivacaine
• Methacholine
• Methoxamine
• Methyldopa
• Morphine
• Moxonidine
• Myxedema coma
• Nadolol
• Nalbuphine
• Nalmefene
• Neonatal lupus erythematosus
• Neostigmine
• Nesiritide
• Neurocardiogenic Syncope
• Neurogenic shock
• Norepinephrine
• Oculocardiac reflex
• Opioid
• Oxymorphone
• PCI Complications: Radiocontrast toxicity
• Phenobarbital
• Phenylephrine
• Phenytoin
• Pilocarpine
• Propafenone
• Propranolol
• Pulseless ventricular tachycardia
• Quinidine
• Rapid sequence induction
• Reserpine
• Right Bundle Branch Block
• Ropivacaine
• Second Degree AV Block
• Sick sinus syndrome
• Sinoatrial Block
• Speedball (drug)
• ST Elevation Myocardial Infarction Complications
• Subarachnoid hemorrhage
• Sulpiride
• Suxamethonium chloride
• Tacrine
• Theobromine poisoning
• Timolol
• Trazodone
• Trypanosoma cruzi
• Typhoid fever
• Uncaria tomentosa
• Vagal episode
• Vasa previa
• Vasovagal syncope
• Vertebral subluxation
• Xylazine

Complete Differential Diagnosis of the Causes of Bradycardia

(By organ system)

Cardiovascular	No underlying causes
Chemical / poisoning	No underlying causes
Dermatologic	No underlying causes
Drug Side Effect	Aceclidine, Acepromazine, Acetylcholinesterase inhibitor, Adenosine, Amiodarone, AMODIAQUINE, Atenolol, Barbiturates, Beta-blockers, Bupivacaine, Calcium channel blocker, Clomipramine, Detomidine, Digitalis, Diltiazem, Diphenhydramine, Donepezil, Doxepin, Glyceryl trinitrate , Hydrocodone, Ibuprofen, Isosorbide dinitrate, Ivabradine, Levobetaxolol, Levobupivacaine, Lidocaine, Lithium, Medetomidine, Mefloquine, Mepivacaine, Methacholine, Methoxamine, Methyldopa, Morphine, Moxonidine, Nadolol, Nalbuphine, Nalmefene, Opioid, Oxymorphone, Phenobarbital, Phenylephrine, Phenytoin, Pilocarpine, Propafenone, Propranolol, Quinidine, Reserpine, Ropivacaine, Sulpiride, Suxamethonium chloride, Tacrine, Timolol, Trazodone, Xylazine,
Ear Nose Throat	No underlying causes
Endocrine	No underlying causes
Environmental	No underlying causes
Gastroenterologic	No underlying causes
Genetic	No underlying causes
Hematologic	No underlying causes
Iatrogenic	No underlying causes
Infectious Disease	No underlying causes
Musculoskeletal / Ortho	No underlying causes
Neurologic	No underlying causes
Nutritional / Metabolic	No underlying causes
Obstetric/Gynecologic	No underlying causes
Oncologic	No underlying causes
Opthalmologic	No underlying causes
Overdose / Toxicity	No underlying causes
Psychiatric	No underlying causes
Pulmonary	No underlying causes
Renal / Electrolyte	No underlying causes
Rheum / Immune / Allergy	No underlying causes
Sexual	No underlying causes
Trauma	No underlying causes
Urologic	No underlying causes
Miscellaneous	No underlying causes

Management

There are two main reasons for treating any cardiac arrhythmias. With bradycardia, the first is to address the associated symptoms, such as fatigue, limitations on how much an individual can physically exert, fainting (syncope), dizziness or lightheadedness, or other vague and non-specific symptoms. The other reason to treat bradycardia is if the person's ultimate outcome (prognosis) will be changed or impacted by the bradycardia. Treatment in this vein depends on whether any symptoms are present, and what the underlying cause is. Primary or idiopathic bradycardia is treated symptomatically if it is significant, and the underlying cause is treated if the bradycardia is secondary.

Treatment

Drug treatment for bradycardia is typically not indicated for patients who are asymptomatic. In symptomatic patients, underlying electrolyte or acid-base disorders or hypoxia should be corrected first. IV atropine may provide temporary improvement in symptomatic patients, although its use should be balanced by an appreciation of the increase in myocardial oxygen demand this agent causes.

Atropine 0.5-1 mg IV or ET q3-5min up to 3 mg total (0.04 mg/kg)

See also

• Normal sinus rhythm
• Tachycardia
• Hypotension

References

Template:WikiDoc Sources